Telemedicine GTM is not a standard SaaS playbook. You are selling to physicians who resist change, patients who default to in-person care, and health systems with 12-month procurement cycles. Getting the market entry wrong burns cash and credibility in a market where second chances are rare.

The Problem

Standard SaaS go-to-market playbooks do not work in healthcare

Product-led growth, viral loops, and self-serve onboarding – the tactics that work in B2B SaaS often fail in telemedicine. Physicians will not adopt new clinical tools through a free trial. Health systems will not sign contracts without security reviews, clinical validation, and legal approval. Applying consumer tech GTM strategies to a regulated healthcare market wastes budget and frustrates your sales team.

Two-sided marketplace dynamics create a cold start problem

Most telemedicine platforms need both physicians and patients to create value. Without physicians, patients have no reason to sign up. Without patients, physicians have no reason to join. This chicken-and-egg problem requires a deliberate sequencing strategy that most telemedicine companies never develop. They try to grow both sides simultaneously and end up with neither.

Geographic expansion runs into licensing walls

Telemedicine is regulated at the state level, which means your go-to-market strategy must account for licensing requirements, prescribing restrictions, and insurance coverage in every market you enter. A nationwide launch is not possible without a state-by-state regulatory plan. Companies that ignore this waste months building demand in markets where they cannot legally operate.

Payer and employer channels add complexity to the sales motion

Selling directly to patients is expensive. Selling through employers or payers creates scale but adds procurement complexity, clinical requirements, and integration demands. Most telemedicine companies try every channel simultaneously without a clear primary motion. The result is a scattered GTM that looks busy but does not compound.

How We Help

We start by defining your primary GTM motion based on where you have the strongest product-market fit signal. For some telemedicine companies, that is a specific clinical specialty where physician adoption is strong. For others, it is an employer channel or a health system partnership model. We identify your beachhead and build the GTM plan around expanding from strength rather than covering every segment.

The sequencing plan addresses the two-sided marketplace challenge directly. We determine whether to lead with physician supply or patient demand, design the incentive structures and onboarding experiences for each side, and build the operational capacity to scale both in sequence. This includes physician recruitment strategies that go beyond job boards – clinical network outreach, medical society partnerships, and referral programs that actually work.

For health system and enterprise sales, we develop account-based strategies that map to healthcare procurement processes. This means identifying clinical champions, building ROI models that speak to health system CFOs, preparing for security and compliance reviews, and creating implementation plans that reduce perceived risk. We build the sales tools and clinical evidence packages that move enterprise deals forward.

Geographic expansion strategy accounts for regulatory reality. We prioritize markets based on licensing feasibility, competitive density, patient demand signals, and payer coverage. Each market entry gets a localized GTM plan that addresses state-specific requirements while maintaining brand consistency.

What we deliver

Primary GTM motion identification and beachhead strategy
Two-sided marketplace sequencing plan
Health system and enterprise account-based sales strategy
State-by-state geographic expansion roadmap
Channel strategy across DTC, employer, and payer segments

The telemedicine companies that scale efficiently pick one GTM motion and get it working before adding the next. Trying to sell DTC, through employers, and to health systems all at once is the fastest way to run out of cash.

Our Methodology

Our 90-day GTM sprint starts with market analysis. We evaluate your product-market fit signals across segments, analyze competitive positioning in target markets, and map the regulatory landscape for your expansion plans. We also assess your current sales and marketing operations to understand what infrastructure exists. By day 30, you have a clear GTM strategy with defined beachhead, sequencing, and resource requirements.

Days 31-60 focus on building the GTM infrastructure. We develop physician recruitment programs, patient acquisition funnels, health system sales materials, and geographic expansion plans. We design the metrics framework that will tell you whether each GTM motion is working before you over-invest. This phase produces the playbooks, templates, and tools your team needs to execute.

The final 30 days involve launch and learning. We activate the primary GTM motion, instrument everything for measurement, and begin iterating based on early signal. We also prepare the expansion plan for secondary channels and markets. You leave with a running GTM operation and a clear roadmap for scaling it.

How We Work

The engagement starts with a two-week intensive strategy phase. We interview your clinical team, sales organization, existing customers, and target prospects. We analyze competitive GTM approaches and regulatory requirements in target markets. This produces the strategic foundation that everything else builds on.

Our team includes a healthcare GTM strategist, a sales operations specialist with health system experience, and a growth marketer who understands physician and patient acquisition. From your side, we need access to your product, clinical, and sales teams, plus customer and prospect data. Weekly strategy sessions keep alignment tight.

Most telemedicine companies begin seeing GTM improvements within 6-8 weeks as new positioning and sales tools enter the market. Health system pipeline development takes 3-6 months given procurement timelines. Physician recruitment acceleration typically shows results within 8-12 weeks. Initial engagements run 3-4 months with ongoing execution support available.

Clear primary GTM motion with measurable traction
Physician recruitment pipeline and onboarding system
Health system sales tools and enterprise deal acceleration
Geographic expansion plan aligned with regulatory requirements

If your telemedicine company needs go-to-market leadership, we should talk.

Expand your marketing team output with our experts

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.

Frequently asked questions

How much does a go-to-market strategy engagement cost for telemedicine?

GTM strategy engagements typically run $40K-65K for the 90-day sprint, covering market analysis, strategy development, and initial execution. Ongoing GTM execution support ranges from $12K-20K per month. This is a fraction of what most telemedicine companies spend on unfocused marketing and sales activities that do not compound. The strategy engagement pays for itself by preventing wasted spend on the wrong channels.

Should we focus on DTC patient acquisition or B2B health system sales?

It depends on your product, your funding, and where you have the strongest early traction. DTC gives you faster feedback loops but higher CAC. Health system sales give you scale but longer cycles. Most successful telemedicine companies start with one and add the other later. We help you determine which motion to lead with based on your specific product-market fit signals, not generic advice.

How do you solve the physician supply problem for telemedicine platforms?

We build physician recruitment strategies that go beyond job postings. This includes clinical network outreach programs, medical society partnerships, structured referral incentives, and physician onboarding experiences designed to reduce friction. We also help you identify which physician specialties and practice models are most receptive to telehealth, so you recruit where interest is highest.

How do you handle multi-state telemedicine expansion?

We build geographic expansion roadmaps that account for state licensing requirements, competitive landscape, patient demand, and payer coverage in each market. States are prioritized based on a composite score that balances opportunity size against regulatory complexity. Each market entry gets a localized launch plan that addresses specific state requirements while maintaining consistent brand positioning.

What makes telemedicine GTM different from other healthcare technology?

The two-sided marketplace dynamic is the biggest difference. Most health tech companies sell a tool to one buyer. Telemedicine companies need physicians and patients on the same platform, often across multiple states with different regulations. The GTM has to solve supply and demand simultaneously while navigating clinical credentialing, state licensing, and payer contracting. It requires healthcare-specific sequencing that standard tech GTM playbooks do not address.

How long does it take to validate a telemedicine go-to-market strategy?

DTC patient acquisition channels typically show validation signals within 4-8 weeks. Physician recruitment strategies show traction within 8-12 weeks. Health system enterprise sales take 3-6 months to generate meaningful pipeline. We design measurement frameworks that give you leading indicators much earlier than closed deals, so you can make resource allocation decisions without waiting for full sales cycles to complete.